Consequences of the COVID-19 pandemic for patients with metabolic diseases

Geltrude Mingrone, Stefan R. Bornstein, Francesco Rubino, Barbara Ludwig, Hannes Rietzsch, Peter E. H. Schwarz, Roman N. Rodionov, Kamlesh Khunti, David Hopkins, Andreas L. Birkenfeld, Bernhard Boehm, Stephanie Amiel, Richard I. G. Holt, Jay S. Skyler, J. Hans Devries, Eric Renard, Robert H. Eckel, Paul Zimmet, K. G. Alberti, Bruno GelonezeJuliana C. Chan, Jean Claude Mbanya, Henry C. Onyegbutulem, Ambady Ramachandran, Abdul Basit, Mohamed Hassanein, Giatgen A. Spinas, Felix Beuschlein

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

The COVID-19 pandemic has stretched healthcare resources and caused severe knock-on effects on patients with metabolic diseases worldwide. We encourage clinicians and patient-interest groups in the field of diabetes and metabolism to raise their voices to ensure adequate care and admission of patients.
Lingua originaleEnglish
pagine (da-a)289-292
Numero di pagine4
RivistaNature Metabolism
Volume3
DOI
Stato di pubblicazionePubblicato - 2021

Keywords

  • metabolic diseases
  • covid 19

Fingerprint

Entra nei temi di ricerca di 'Consequences of the COVID-19 pandemic for patients with metabolic diseases'. Insieme formano una fingerprint unica.

Cita questo